[Skip to content]

EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - Awareness EPDA - Coping Strategies EPDA - Medical Information EPDA - Patient Guide EPDA - Site Map EPDA - Rewrite Tomorrow
EUROPEAN PARKINSON'S DISEASE ASSOCIATION
.

PDNS Core Competencies: The Partners



The Working Group on PD  

The Working Group on PD was formed by the World Health organisation (WHO) in 1997, to develop guidelines for the WHO-led international efforts to control PD.

The group originally consisted of leading specialists in PD from Argentina, Austria, Canada, Germany, Russia, South Africa, Spain, UK and USA, as well as representatives from the EPDA. In order to fully reflect the WHO regions of America, Europe, East Mediterranean, Africa, South East Asia and Western Pacific, membership has since increased to include India, Japan, and Jordan. Annual meetings have been held alongside World PD Day celebrations in Spain, USA, Argentina, Japan, Russia, India and South Africa.

The aims and objectives of the group have been to develop a Global PD Alliance, to utilize the expertise of the membership working in partnership with lay organisations within the WHO regions, and ultimately transfer the 'Charter for people with PD' into a Global Declaration.

For further information see Working Group on PD recommendations.


The European Parkinson's Disease Association (EPDA)  

The EPDA was formed June 1992 in Munich with a membership of 9 European Parkinson's Patient organisations. In 2006, its membership has increased to 38 from Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Faeroe Islands, Finland, France, Hungary, Iceland, Ireland, Israel, Italy, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Russia, Slovenia, Sweden, Switzerland, Turkey, Ukraine, UK, and Yugoslavia. It also has 7 Associate members including the Movement Disorder Society, the European Federation of Neurological Associations and the Tremor Foundation.

The EPDA is a non-religious, non-political and non-profit making organisation concerned with the health and welfare of people living with Parkinson's disease and their families.

The EPDA has provided an important forum to work in partnership and collaboration with European organisations, both patient and neurological, the European Commission, the World Health Organisation, the World Federation of Neurology and the pharmaceutical industry. This partnership has enabled the development of research projects into quality of life issues and conferences for multidisciplinary teams and people with Parkinson's of any age.

For further information see www.epda.eu.com/businessPlan


The International Council of Nurses  

The International Council of Nurses (ICN) is a federation of national nurses’ associations (NNAs), representing nurses in more than 120 countries. Founded in 1899, ICN is the world’s first and widest reaching international organisation for health professionals.  Operated by nurses for nurses, ICN works to ensure quality nursing care for all, sound health policies globally, the advancement of nursing knowledge, and the presence worldwide of a respected nursing profession and a competent and satisfied nursing workforce.

ICN has a long history in undertaking major activities that target quality practice.  Its International Regulation Project has been influential globally in helping ensure nurses are safe and competent and the public is protected.  ICN’s standards and competency work is driven by the belief that comparable standards and competencies, both within a country and in the international context, are key to reaching higher universal outcomes for health care. 

ICN has considerable experience in managing grants of various amounts, and has worked with foundations and funding agencies such as the W.K. Kellogg Foundation, Merck Foundation, the Government of New Zealand, the Swedish International Development Cooperation Agency, and the Danish Agency for Development Assistance as well as numerous nongovernmental agencies.  Additionally, ICN has extensive experience in implementing and sustaining complex international projects that may include several countries, a number of phases and multiple methodologies.

For further information see www.icn.ch


Industrial Partners

The EPDA would like to acknowledge the partnership of the following companies without whose support, this project would not be possible.


Britannia Pharmaceuticals Ltd
H Lundbeck A/S
Novartis Logo
Orion
Solvay Pharmaceuticals